# Neurology (epilepsy and functional neurological disorder) Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: James Madison (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN007-SYN
- Date: 2026-04-30
- Fictional facility: St. Posthumous Health Center
- Fictional author: Rosalind Okafor-Haverford, MD
- Calendar frame: modern shifted

- Requested by: Josiah Pembroke-Achebe, MD

## Reason for consultation

A 23-year-old man with two years of recurrent sudden episodes of unresponsiveness, two or three a month, unchanged on levetiracetam started without an EEG, with moderate depression and anxiety. Please establish whether these are epileptic seizures, functional/dissociative seizures, syncope, or something else, ideally by capturing events on video-EEG, and advise on the antiseizure medicine, treatment, driving, and his studies. **S**

## History

Mr. Madison is seen at the request of Dr. Pembroke-Achebe on the third day of video-EEG monitoring, and again this morning before discharge. He describes two years of spells that begin with a feeling of distance and heaviness, after which he cannot move or answer though he may hear what is said; they last two to ten minutes, end gradually, and leave him tearful and tired. There is no aura of rising sensation, déjà vu, automatisms he is aware of, tongue biting, incontinence, injury, or events from sleep. They began during a period of intense study and little sleep and are most frequent after long days. There is no history of febrile seizures, head injury, or meningitis, and no palpitations or exertional events. Levetiracetam for four months has made no difference and has made him irritable. He reports low mood and constant worry about his future and his health, without suicidal thoughts. He has not driven since his first primary care visit. **S**

## Examination

| System | Finding |
|---|---|
| General | Slight, tired, courteous |
| Neurological | Normal cranial nerves, strength, tone, reflexes, coordination, sensation, and gait |
| Mental status | Low mood with constricted affect; logical; no suicidal ideation; good insight |

BP 110/68 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 54.2 kg; BMI 19.2 kg/m². All vital signs are synthetic.

## Data reviewed

Video-EEG for 72 hours with sleep deprivation, hyperventilation, and photic stimulation, on levetiracetam: two habitual events recorded (2 minutes 40 seconds and 6 minutes), with eyes closed and resisting opening, fluctuating unresponsiveness, and slow side-to-side head movements; the EEG showed a continuous normal waking posterior rhythm during both, with no ictal or postictal change; interictal EEG normal awake and asleep; he confirmed both events as typical. Brain MRI with an epilepsy protocol: normal. ECG: sinus rhythm, QTc 404 ms. Blood count, metabolic panel, glucose, calcium, and TSH: normal. PHQ-9 12 and GAD-7 13 today; neuropsychiatric assessment on the unit: generalized anxiety disorder and a moderate depressive episode, without psychotic or bipolar features. PHQ-9: 12; GAD-7: 13. All results are synthetic.

## Assessment

1. **Functional/dissociative seizures, documented by video-EEG** (F44.5). Both habitual events were captured with a normal waking EEG throughout, closed and resisting eyes, and a fluctuating course: with a typical history and normal interictal EEG and MRI, this is a documented diagnosis by the ILAE criteria. I find no evidence of epilepsy: focal impaired-awareness seizures of this length would be expected to change the EEG, and the events have not responded to levetiracetam. Syncope does not explain events of several minutes with closed eyes and a normal EEG. The onset under heavy study and little sleep, with anxiety and depression, fits the usual picture. I use the ILAE task force term functional/dissociative seizures with him. **S**
2. **Taking an antiseizure medicine without a confirmed diagnosis** (Z79.899). Levetiracetam is not needed and is probably adding to his irritability; it should be withdrawn. **S**
3. **Major depressive disorder, single episode, moderate** (F32.1). Depression and generalized anxiety are present and should be treated alongside the seizures. **S**

## Recommendations

1. Diagnosis: functional/dissociative seizures, documented level; not epilepsy and not syncope.
2. Video-EEG was indicated and has captured his habitual events; no further EEG is needed unless a different kind of event appears.
3. Withdraw levetiracetam over three weeks (250 mg twice daily for two weeks, 250 mg at night for one week, then stop), with no driving during the taper; record on his emergency card that typical events should not be treated with benzodiazepines or antiseizure medicines.
4. Explain the diagnosis as I did yesterday: name it; say that it is real, common, and not epilepsy or put on; explain how the brain can switch off awareness under strain; say why antiseizure medicines do not help; say that it can improve with treatment; give a written summary and a reliable online resource; and review his questions at the next visit.
5. Twelve weekly sessions of CBT-informed psychotherapy for functional seizures with an event diary, grounding techniques, and a relapse-prevention plan; treat the depression and anxiety in the same course, and add an SSRI such as sertraline if they persist, remembering that sertraline alone does not reduce the events.
6. No driving until he has been free of events for at least three months, in line with the AAN position and state rules; showers not baths, no swimming alone; a regular sleep window of at least seven hours; testing accommodations for his examinations; continue the safety plan.

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Communication

Discussed with Dr. Pembroke-Achebe the same day. Mr. Madison heard the explanation, saw the recordings, and agrees with the plan; he was given a written summary. **S**

## Follow-up

Primary care continues with Dr. Pembroke-Achebe. I will see him again if new kinds of events appear, if events do not fall after the course of psychotherapy, or to confirm that he may drive. **S**

## Guideline basis

- LaFrance WC Jr, et al. Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force. Epilepsia 2013;54(11):2005-2018 (PMID 24111933) (2013), International League Against Epilepsy
- Hingray C, et al. Functional/dissociative seizures: Proposal for a new diagnostic label and definition by the ILAE task force. Epilepsia 2025;66(11):4162-4182 (PMID 40884444) (2025), International League Against Epilepsy
- Fisher RS, et al. Operational classification of seizure types by the International League Against Epilepsy. Epilepsia 2017;58(4):522-530 (PMID 28276060) (2017), International League Against Epilepsy
- Hall-Patch L, et al. Acceptability and effectiveness of a strategy for the communication of the diagnosis of psychogenic nonepileptic seizures. Epilepsia 2010;51(1):70-78 (PMID 19453708) (2010), Epilepsia (International League Against Epilepsy)
- Stone J, et al. Explanation as treatment for functional neurologic disorders. Handb Clin Neurol 2016;139:543-553 (PMID 27719870) (2016), Handbook of Clinical Neurology (Elsevier)
- LaFrance WC Jr, et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry 2014;71(9):997-1005 (PMID 24989152) (2014), JAMA Psychiatry
- Goldstein LH, et al. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. Lancet Psychiatry 2020;7(6):491-505 (PMID 32445688) (2020), Lancet Psychiatry
- Tolchin B, et al. Seizures, Driver Licensure, and Medical Reporting Update: An AAN Position Statement. Neurology 2025;104(7):e213459 (PMID 40073306) (2025), American Academy of Neurology, American Epilepsy Society, and Epilepsy Foundation of America
